Anatolis Pharmaceuticals Private Limited
About Anatolis Pharmaceuticals Private Limited
Data last updated:
Anatolis Pharmaceuticals Private Limited is a private limited company based in Miraroad East, Maharashtra, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 14 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2017PTC292369. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ankita Bharat Vishwakarma and Bharat Rajaram Vishwakarma.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at Shop No 10 B Wing Samarpan Bldg No 8 Kanakiya Layout, Miraroad East, Maharashtra, India – 401107.
As per the financials filed for FY 2018, the company reported a revenue of ₹1.16 Lakh. For the same year it recorded a net loss of ₹35,821 (net margin -31%) and EBITDA of -₹35,821 (EBITDA margin -31%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No 10 B Wing Samarpan Bldg No 8 Kanakiya Layout, Miraroad East, Maharashtra, India – 401107
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Anatolis Pharmaceuticals Private Limited
The main business activity of Anatolis Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Anatolis Pharmaceuticals Private Limited FY 2018 filings available
Anatolis Pharmaceuticals Private Limited reported revenue of ₹1.16 Lakh for FY 2018.
Financial Statement Summary of Anatolis Pharmaceuticals Private Limited
| Metrics | FY 2017-18 | FY 2016-17 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹35,821 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹35,821 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Anatolis Pharmaceuticals Private Limited
| Metrics | FY 2017-18 | FY 2016-17 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -31% | •••• |
| Net Profit Margin | -31% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Anatolis Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Anatolis Pharmaceuticals Private Limited
Anatolis Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ankita Bharat Vishwakarma | Director | 14 May 2021 | 5 Years 5 Months | Current |
| Bharat Rajaram Vishwakarma | Director | 14 Mar 2017 | 9 Years 7 Months | Current |
Peer Comparison of Anatolis Pharmaceuticals Private Limited
Anatolis Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rynish Pharmaceuticals Private Limited | ₹1.17 Lakh (FY 2025) | •••• | •••• | -98.0% | •••• | Mumbai, Maharashtra, India |
| MMP Pharmaceuticals Private Limited | ₹1.16 Lakh (FY 2025) | •••• | •••• | 258.0% | •••• | Thane, Maharashtra, India |
| Inds Pharmaceuticals Private Limited | ₹1.16 Lakh (FY 2025) | •••• | •••• | -58.0% | •••• | Sanpada, Maharashtra, India |
| Zenista Pharmaceuticals Private Limited | ₹1.16 Lakh (FY 2022) | •••• | •••• | -89.0% | •••• | Patna, Bihar, India |
| Dzyris Pharmaceuticals Private Limited | ₹1.16 Lakh (FY 2023) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Anatolis Pharmaceuticals Private Limited this company | ₹1.16 Lakh (FY 2018) | •••• | •••• | •••• | Miraroad East, Maharashtra, India | |
| Samarbiotic Pharmaceuticals (OPC) Private Limited | ₹1.15 Lakh (FY 2019) | •••• | •••• | •••• | Talab Tillo, Jammu and Kashmir, India | |
| Srinaas Chemicals and Pharmaceuticals Private Limited | ₹1.15 Lakh (FY 2024) | •••• | •••• | •••• | Bibinagar, Telangana, India | |
| Montage Pharmaceuticals Pvt Ltd | ₹1.15 Lakh (FY 2023) | •••• | •••• | -70.0% | •••• | Mehsana, Gujarat, India |
| Oshid Pharmaceuticals Pvt Ltd | ₹1.14 Lakh (FY 2025) | •••• | •••• | -78.0% | •••• | Punjab, India |
| Hesse Pharmaceuticals Private Limited | ₹1.14 Lakh (FY 2025) | •••• | •••• | -97.0% | •••• | Pathankot, Punjab, India |
Peers are the five companies nearest above and the five nearest below Anatolis Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Anatolis Pharmaceuticals Private Limited
Anatolis Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Anatolis Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Anatolis Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Anatolis Pharmaceuticals Private Limited
Anatolis Pharmaceuticals Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Ankita Bharat Vishwakarma was appointed as Director on 14 May 2021.
Credit Ratings, Litigation & Regulatory Alerts for Anatolis Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Anatolis Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Anatolis Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Anatolis Pharmaceuticals Private Limited
Anatolis Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Anatolis Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anatolis Pharmaceuticals Private Limited
Anatolis Pharmaceuticals is an active private limited company based in Miraroad East, Maharashtra, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 14 March 2017 (9+ years old) and is registered under CIN U24304MH2017PTC292369.
Anatolis Pharmaceuticals reported revenue of ₹1.16 Lakh for FY 2018.
Anatolis Pharmaceuticals has 2 current directors:
- Ankita Bharat Vishwakarma - Director
- Bharat Rajaram Vishwakarma - Director
Anatolis Pharmaceuticals reported a net loss of ₹35,821 (net margin -31%) and EBITDA of -₹35,821 (EBITDA margin -31%) for FY 2018, as per its filed financial statements.
No. Anatolis Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Anatolis Pharmaceuticals is U24304MH2017PTC292369. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anatolis Pharmaceuticals was incorporated on 14 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Anatolis Pharmaceuticals by revenue are Rynish Pharmaceuticals Private Limited, MMP Pharmaceuticals Private Limited, Inds Pharmaceuticals Private Limited, Zenista Pharmaceuticals Private Limited, Dzyris Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Ankita Bharat Vishwakarma was appointed as Director on 14 May 2021. Rajaram Ramsinh Vishwakarma ceased to be Director on 14 May 2021. Bharat Rajaram Vishwakarma was appointed as Director on 14 Mar 2017.
The registered office of Anatolis Pharmaceuticals is at Shop No 10 B Wing Samarpan Bldg No 8 Kanakiya Layout, Miraroad East, Maharashtra, India – 401107.
Anatolis Pharmaceuticals has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.